Biogen Inc. buy Royal Bank of Canada
Start price
02.08.24
/
50%
€188.45
Target price
02.08.25
€267.50
Performance (%)
-40.94%
Price
23.07.25
€111.30
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is performing very badly with a performance of -40.94%. This prediction currently runs until 02.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.815% | 0.815% |
| iShares Core DAX® | 1.097% | 4.456% |
| iShares Nasdaq 100 | -0.089% | 4.218% |
| iShares Nikkei 225® | 5.046% | 5.461% |
| iShares S&P 500 | 0.416% | 3.910% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $282.00 to $292.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat